Pathophysiology of pulmonary nontuberculous mycobacterial (NTM) disease

Respir Investig. 2023 Mar;61(2):135-148. doi: 10.1016/j.resinv.2022.12.002. Epub 2023 Jan 12.

Abstract

In recent years, the incidence and prevalence of pulmonary nontuberculous mycobacterial (NTM) disease have increased worldwide. Although the reasons for this increase are unclear, dealing with this disease is essential. Pulmonary NTM disease is a chronic pulmonary infection caused by NTM bacteria, which are ubiquitous in various environments. In Japan, Mycobacterium avium-intracellulare complex (MAC) accounts for approximately 90% of the causative organisms of pulmonary NTM disease, which is also called pulmonary MAC disease or pulmonary MAI disease. It is important to elucidate the pathophysiology of this disease, which occurs frequently in postmenopausal women despite the absence of obvious immunodeficiency. The pathophysiology of this disease has not been fully elucidated; however, it can largely be divided into bacterial (environmental) and host-side problems. The host factors can be further divided into immune and airway problems. The authors suggest that the triangular relationship between bacteria, immunity, and the airway is important in the pathophysiology of this disease. The latest findings on the pathophysiology of pulmonary NTM disease are reviewed.

Keywords: IFN-γ/IL-12 axis; Mucociliary clearance; Nontuberculous mycobacteria (NTM); Shower head; Soil.

Publication types

  • Review

MeSH terms

  • Female
  • Humans
  • Lung
  • Lung Diseases* / epidemiology
  • Mycobacterium Infections, Nontuberculous* / epidemiology
  • Mycobacterium avium Complex
  • Nontuberculous Mycobacteria